Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instruments related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers FlashAngio caFFR System, a coronary angiography-derived fractional flow reserve measurement system; FlashAngio caIMR System, which provides auxiliary diagnosis of coronary artery diseases; and disposable blood pressure transducer, which is used in conjunction with specialized equipment. In addition, it provides reagents and others installation and training services. Rainmed Medical Limited was founded in 2014 and is headquartered in Suzhou, China.
Часто задаваемые вопросы
В каком секторе работает Rainmed Medical Ltd (2297)?
Rainmed Medical Ltd относится к сектору Здравоохранение.
Какова текущая цена акций Rainmed Medical Ltd (2297)?
По последним данным, цена акций Rainmed Medical Ltd составляет 0,16 HK$, предыдущее закрытие — 0,16 HK$.
Выплачивает ли Rainmed Medical Ltd (2297) дивиденды?
Нет, Rainmed Medical Ltd не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Rainmed Medical Ltd (2297)?
У компании Rainmed Medical Ltd бета 0.568, что указывает на более низкую волатильность по сравнению с рынком в целом.
